前列腺癌立体定向放疗每日计划适应的剂量学获益
该回顾性研究基于32例前列腺癌患者按PACE-C方案(40 Gy分5次)生成的计划,利用合成CT评估四种适应策略的剂量学获益。与未适应IGRT相比,各适应策略均降低膀胱V37Gy和直肠V36Gy,惩罚评分显示剂量违规减少75.7%–93.2%。结论认为每日计划适应可充分恢复相关剂量标准。
要点
- 每日计划适应可降低膀胱V37Gy和直肠V36Gy,减少剂量违规。
- ART1平均耗时2.6分钟,直肠剂量与ART2无显著差异。
- SAM适应主要保障靶区覆盖,全再优化主要改善OAR保护。
核心结论
- 治疗计划适应能够在每日治疗中充分恢复相关剂量标准。
- SAM适应策略的剂量学获益主要通过确保足够的靶区覆盖实现,而全再优化主要改善危及器官保护。
研究设计与样本
- 回顾性研究,对32例前列腺癌患者的治疗计划按PACE-C试验方案(40 Gy分5次)生成并分析。
- 利用先前训练的循环生成对抗网络算法,从五次每日锥形束CT生成合成CT,并在合成CT上进行四种适应策略的剂量计算。
主要发现
- 与未适应的IGRT相比,ART1、ART2和ART3将膀胱V37Gy均值从7.4cm3分别降至5.9cm3、6.1cm3和5.2cm3。
- 与未适应的IGRT相比,ART1、ART2和ART3将直肠V36Gy均值从2.0cm3分别降至1.4cm3、1.4cm3和1.0cm3。
- 基于总患者群体累积的惩罚评分显示,适应使剂量违规分别减少79.2%、75.7%和93.2%。
- ART1方案平均需要2.6分钟,其直肠剂量与ART2方案无显著差异。
关键数值与推荐
- PACE-C试验治疗方案为40 Gy分5次。
- 评估的剂量体积参数包括膀胱V37Gy和直肠V36Gy。
- 四种适应策略为:未适应IGRT、SAM适应联合分段权重优化(ART1)、额外形状优化(ART2)以及全再优化(ART3)。
临床怎么用
- 每日计划适应可用于恢复前列腺癌立体定向放疗的相关剂量标准。
- SAM适应可在较短时间内(平均2.6分钟)实现剂量学获益,全再优化则更多改善OAR保护,有助于指导适应策略选择。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypofractionation is increasingly being applied in radiotherapy for prostate cancer, requiring higher accuracy of daily treatment deliveries than in conventional image-guided radiotherapy (IGRT). Different adaptive radiotherapy (ART) strategies were evaluated with regard to dosimetric benefits. METHODS: Treatments plans for 32 patients were retrospectively generated and analyzed according to the PACE-C trial treatment scheme (40 Gy in 5 fractions). Using a previously trained cycle-generative adversarial network algorithm, synthetic CT (sCT) were generated out of five daily cone-beam CT. Dose calculation on sCT was performed for four different adaptation approaches: IGRT without adaptation, adaptation via segment aperture morphing (SAM) and segment weight optimization (ART1) or additional shape optimization (ART2) as well as a full re-optimization (ART3). Dose distributions were evaluated regarding dose-volume parameters and a penalty score. RESULTS: Compared to the IGRT approach, the ART1, ART2 and ART3 approaches substantially reduced the V37Gy(bladder) and V36Gy(rectum) from a mean of 7.4cm3 and 2.0cm3 to (5.9cm3, 6.1cm3, 5.2cm3) as well as to (1.4cm3, 1.4cm3, 1.0cm3), respectively. Plan adaptation required on average 2.6 min for the ART1 approach and yielded doses to the rectum being insignificantly different from the ART2 approach. Based on an accumulation over the total patient collective, a penalty score revealed dosimetric violations reduced by 79.2%, 75.7% and 93.2% through adaptation. CONCLUSION: Treatment plan adaptation was demonstrated to adequately restore relevant dose criteria on a daily basis. While for SAM adaptation approaches dosimetric benefits were realized through ensuring sufficient target coverage, a full re-optimization mainly improved OAR sparing which helps to guide the decision of when to apply which adaptation strategy.
引用
- Eckl M, Sarria GR, Springer S, et al. Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy. Radiat Oncol. 2021. PMID: 34348765. doi:10.1186/s13014-021-01872-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。